Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis

The Journal of Clinical Investigation
Keith Syson ChanJ DiGiovanni

Abstract

Constitutive activation of signal transducer and activator of transcription 3 (Stat3) has been found in a wide spectrum of human malignancies. Here, we have assessed the effect of Stat3 deficiency on skin tumor development using the 2-stage chemical carcinogenesis model. The epidermis of Stat3-deficient mice showed a significantly reduced proliferative response following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) because of a defect in G1-to-S-phase cell cycle progression. Treatment with the tumor initiator 7,12-dimethylbenz[a]anthracene (DMBA) resulted in a significant increase in the number of keratinocyte stem cells undergoing apoptosis in the bulge region of hair follicles of Stat3-deficient mice compared with nontransgenic littermates. Notably, Stat3-deficient mice were completely resistant to skin tumor development when DMBA was used as the initiator and TPA as the promoter. Abrogation of Stat3 function using a decoy oligonucleotide inhibited the growth of initiated keratinocytes possessing an activated Ha-ras gene, both in vitro and in vivo. In addition, injection of Stat3 decoy into skin tumors inhibited their growth. To our knowledge, these data provide the first evidence that Stat3 is...Continue Reading

References

Jan 1, 1992·Pharmacology & Therapeutics·J DiGiovanni
Oct 6, 1995·The Journal of Biological Chemistry·C AlbaneseR G Pestell
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·I B RosenwaldE V Schmidt
Aug 23, 1996·The Journal of Biological Chemistry·J N LavoieJ Pouysségur
Apr 16, 1998·The Journal of Biological Chemistry·M IchibaT Hirano
Jan 23, 1999·Current Opinion in Cell Biology·T P Neufeld, B A Edgar
Jun 25, 1999·Cell·Y GengP Sicinski
Aug 24, 1999·Cell·J F BrombergJ E Darnell
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·H HermekingK W Kinzler
Jul 6, 2000·The Journal of Clinical Investigation·R J Morris
Nov 21, 2000·Current Opinion in Oncology·J M GradL H Boise
Feb 13, 2001·The Journal of Clinical Investigation·P K Epling-BurnetteT P Loughran
May 18, 2001·Nature·P Blume-Jensen, T Hunter
Mar 21, 2002·Nature Reviews. Cancer·M Malumbres, M Barbacid
May 8, 2002·The Journal of Clinical Investigation·Jacqueline Bromberg
Jun 5, 2002·Nature Reviews. Cancer·William C Hahn, Robert A Weinberg
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·David E Levy, J E Darnell
Oct 3, 2002·Nature Reviews. Cancer·James E Darnell
Oct 31, 2002·The Journal of Investigative Dermatology·Christopher S Potten, Catherine Booth
Mar 13, 2003·Molecular Biology of the Cell·Christoph Schorl, John M Sedivy
Mar 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Paul L LeongJennifer Rubin Grandis
Apr 1, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jiro UmedaJunji Takeda
May 29, 2003·The Journal of Biological Chemistry·Sichuan XiJennifer Rubin Grandis
Jun 5, 2003·Nature Reviews. Cancer·Jesus Perez-Losada, Allan Balmain

❮ Previous
Next ❯

Citations

Sep 4, 2008·Cancer Chemotherapy and Pharmacology·Malabika SenJennifer R Grandis
Dec 29, 2010·Cell Research·Guobin He, Michael Karin
Feb 14, 2006·Nature Chemical Biology·Hendrik LueschPeter G Schultz
Aug 29, 2009·Nature Protocols·Erika L AbelJohn DiGiovanni
Aug 15, 2012·Nature Reviews. Urology·Philip Levy HoKeith Syson Chan
Feb 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Agnieszka Kobielak, Elaine Fuchs
Jun 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Monika KasprzyckaMariusz A Wasik
Dec 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michal MarzecMariusz A Wasik
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Keith Syson ChanIrving L Weissman
Dec 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Anastasia Tsaalbi-ShtylikNiels de Wind
Sep 21, 2012·The Journal of Biological Chemistry·Dongsheng GuJingwu Xie
Dec 4, 2008·The Journal of Biological Chemistry·Zhu ZhangShougang Zhuang
Oct 31, 2008·Molecular Biology of the Cell·Omedul IslamKlaus Heese
Feb 9, 2008·Genes & Development·Núria de la IglesiaAzad Bonni
May 8, 2007·Cancer Research·Carol S TrempusRaymond W Tennant
Dec 17, 2010·Cancer Research·Lin WangHua Yu
May 19, 2011·Cancer Research·Ryan B CorcoranNabeel Bardeesy
Dec 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mohamed Abou-GhazalAmy B Heimberger
Aug 16, 2011·Molecular Cancer Research : MCR·Peng ZhangZhenghe Wang
Mar 18, 2010·Cancer Prevention Research·Ana M GameroNancy H Colburn
May 17, 2013·The Journal of Clinical Investigation·Xiuting ChenLibing Song
Dec 6, 2011·BMC Cancer·Wen-Yong WuXiang-Ling Meng
May 19, 2010·Cell Division·Andrew JarnickiMatthias Ernst
Oct 12, 2010·Breast Cancer Research : BCR·Kenneth LeslieJacqueline Bromberg
Feb 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pasquale Sansone, Jacqueline Bromberg

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
PCR

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.